. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy. Alzheimers Res Ther. 2020 Nov 30;12(1):159. PubMed. Correction.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. UB-312 Synuclein Vaccine Safe in Controls. Next Up: Parkinson's.

Therapeutics

  1. UB-312